- Protenus, founded in 2014 and headquartered in Baltimore, Maryland, specializes in healthcare compliance analytics, focusing on patient privacy and drug diversion monitoring within the healthcare sector.
- In January 2025, Protenus was acquired by Bluesight to enhance its compliance analytics capabilities and integrate patient privacy monitoring features into Bluesight's platform.
- Protenus's solutions are utilized by healthcare organizations to detect privacy violations and prevent drug diversion, making them a critical partner in maintaining compliance and safety standards.
- The ideal buyer for Protenus includes healthcare organizations seeking to enhance their compliance measures, reduce risks associated with privacy violations, and ensure adherence to regulatory standards, making it a timely solution in the evolving healthcare landscape.
Protenus operates with a streamlined workforce, consisting of a single department categorized as 'Other' with a headcount of 1. This singular departmental structure suggests a highly specialized focus, potentially indicating a lean operational model. The absence of additional departments may reflect a concentrated approach to software development, allowing for agility and direct communication within the team.
The entire workforce of Protenus is situated in Baltimore, Maryland, with a total headcount of 1. This geographic concentration indicates a centralized operational strategy, which may facilitate collaboration and cohesion among team members. The lack of remote or distributed locations suggests a preference for in-person engagement, aligning with the company's current scale and operational needs.
